CN Patent
CN107661294B — 抗高血压药物脂肪乳注射剂及其制备方法
Assigned to Wuhan Conform New Pharm Co ltd · Expires 2020-04-14 · 6y expired
What this patent protects
本发明公开了抗高血压药物脂肪乳注射剂及其制备方法,其中,该抗高血压药物脂肪乳注射剂为丁酸氯维地平脂肪乳注射剂,其包含:丁酸氯维地平;以及药学上可接受的药用赋形剂,所述药用赋形剂包括:油相介质,乳化剂,渗透压调节剂,稳定剂,金属螯合剂,pH值调节剂和注射用水。该抗高血压药物脂肪乳注射剂质量稳定、安全性高、且对血管无刺激性。
USPTO Abstract
本发明公开了抗高血压药物脂肪乳注射剂及其制备方法,其中,该抗高血压药物脂肪乳注射剂为丁酸氯维地平脂肪乳注射剂,其包含:丁酸氯维地平;以及药学上可接受的药用赋形剂,所述药用赋形剂包括:油相介质,乳化剂,渗透压调节剂,稳定剂,金属螯合剂,pH值调节剂和注射用水。该抗高血压药物脂肪乳注射剂质量稳定、安全性高、且对血管无刺激性。
Drugs covered by this patent
- Cleviprex (CLEVIDIPINE) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.